Higgins Sara C, Montgomery Guy H, Bovbjerg Dana H
Biobehavioral Medicine Program, Department of Oncological Sciences, Mount Sinai School of Medicine, New York, NY 10029-6574, USA.
Support Care Cancer. 2007 Feb;15(2):171-7. doi: 10.1007/s00520-006-0113-y. Epub 2006 Aug 3.
Posttreatment nausea (PTN) is a common side effect of cytotoxic cancer chemotherapy. Previous retrospective research has suggested that the severity of PTN may be, in part, related to pretreatment psychological factors (e.g., emotional distress and expectations for nausea).
The purpose of the present study was to examine these relationships prospectively, with distress and nausea expectations assessed by validated self-report measures completed in the clinic before the participants' first outpatient treatment infusion and with PTN (0-100) assessed by end-of-day diaries completed at home on each of the first 5 days after treatment. The participants were chemotherapy-naive women (N=56) scheduled for standard adjuvant treatment for stage I-II breast cancer (mean age=45.6 years). PTN was evaluated for acute (days 0-1) and delayed (days 2-5) responses.
The results revealed a significant relationship between pretreatment distress and the severity of the patients' subsequent delayed nausea (p<0.007) but not a relationship with acute PTN (p<0.19). No significant relationships were seen between expectations and PTN. However, there was evidence of an additive effect of nausea expectations and distress, with the highest levels of delayed PTN seen in patients with both expectations and higher distress before treatment. The results suggest a selective effect of pre-infusion psychological variables on the delayed phase of nausea after chemotherapy, consistent with an emerging view that the different phases of nausea are mediated by different neural pathways.
Future research should examine the possibility that delayed nausea, which the literature suggests is more resistant to antiemetic drugs than acute nausea, might be responsive to psychological interventions before initial treatments.
治疗后恶心(PTN)是细胞毒性癌症化疗常见的副作用。以往的回顾性研究表明,PTN的严重程度可能部分与治疗前的心理因素有关(例如,情绪困扰和对恶心的预期)。
本研究的目的是前瞻性地研究这些关系,通过在参与者首次门诊治疗输液前在诊所完成的经过验证的自我报告测量方法评估困扰和恶心预期,并通过治疗后前5天每天在家中完成的每日结束时日记评估PTN(0-100)。参与者为计划接受I-II期乳腺癌标准辅助治疗的初治化疗女性(N=56)(平均年龄=45.6岁)。评估PTN的急性(第0-1天)和延迟(第2-5天)反应。
结果显示,治疗前困扰与患者随后延迟性恶心的严重程度之间存在显著关系(p<0.007),但与急性PTN无关系(p<0.19)。预期与PTN之间未发现显著关系。然而,有证据表明恶心预期和困扰存在相加效应,在治疗前既有预期又有较高困扰的患者中延迟性PTN水平最高。结果表明输液前心理变量对化疗后恶心延迟期有选择性影响,这与一种新出现的观点一致,即恶心的不同阶段由不同的神经通路介导。
未来的研究应探讨延迟性恶心(文献表明其比急性恶心更难用止吐药治疗)在初始治疗前可能对心理干预有反应的可能性。